199 related articles for article (PubMed ID: 23825080)
1. 20-HETE induces remodeling of renal resistance arteries independent of blood pressure elevation in hypertension.
Ding Y; Wu CC; Garcia V; Dimitrova I; Weidenhammer A; Joseph G; Zhang F; Manthati VL; Falck JR; Capdevila JH; Schwartzman ML
Am J Physiol Renal Physiol; 2013 Sep; 305(5):F753-63. PubMed ID: 23825080
[TBL] [Abstract][Full Text] [Related]
2. Androgen-dependent hypertension is mediated by 20-hydroxy-5,8,11,14-eicosatetraenoic acid-induced vascular dysfunction: role of inhibitor of kappaB Kinase.
Wu CC; Cheng J; Zhang FF; Gotlinger KH; Kelkar M; Zhang Y; Jat JL; Falck JR; Schwartzman ML
Hypertension; 2011 Apr; 57(4):788-94. PubMed ID: 21321301
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin II receptor blockade or deletion of vascular endothelial ACE does not prevent vascular dysfunction and remodeling in 20-HETE-dependent hypertension.
Garcia V; Joseph G; Shkolnik B; Ding Y; Zhang FF; Gotlinger K; Falck JR; Dakarapu R; Capdevila JH; Bernstein KE; Schwartzman ML
Am J Physiol Regul Integr Comp Physiol; 2015 Jul; 309(1):R71-8. PubMed ID: 25924878
[TBL] [Abstract][Full Text] [Related]
4. Androgen-sensitive hypertension associates with upregulated vascular CYP4A12-20-HETE synthase.
Wu CC; Mei S; Cheng J; Ding Y; Weidenhammer A; Garcia V; Zhang F; Gotlinger K; Manthati VL; Falck JR; Capdevila JH; Schwartzman ML
J Am Soc Nephrol; 2013 Jul; 24(8):1288-96. PubMed ID: 23641057
[TBL] [Abstract][Full Text] [Related]
5. Renal vascular cytochrome P450-derived eicosanoids in androgen-induced hypertension.
Singh H; Schwartzman ML
Pharmacol Rep; 2008; 60(1):29-37. PubMed ID: 18276983
[TBL] [Abstract][Full Text] [Related]
6. Androgen-induced hypertension in angiotensinogen deficient mice: role of 20-HETE and EETS.
Garcia V; Cheng J; Weidenhammer A; Ding Y; Wu CC; Zhang F; Gotlinger K; Falck JR; Schwartzman ML
Prostaglandins Other Lipid Mediat; 2015; 116-117():124-30. PubMed ID: 25526688
[TBL] [Abstract][Full Text] [Related]
7. Vascular cytochrome P450 4A expression and 20-hydroxyeicosatetraenoic acid synthesis contribute to endothelial dysfunction in androgen-induced hypertension.
Singh H; Cheng J; Deng H; Kemp R; Ishizuka T; Nasjletti A; Schwartzman ML
Hypertension; 2007 Jul; 50(1):123-9. PubMed ID: 17548721
[TBL] [Abstract][Full Text] [Related]
8. Blockade of 20-hydroxyeicosatetraenoic acid receptor lowers blood pressure and alters vascular function in mice with smooth muscle-specific overexpression of CYP4A12-20-HETE synthase.
Agostinucci K; Hutcheson R; Hossain S; Pascale JV; Villegas E; Zhang F; Adebesin AM; Falck JR; Gupte S; Garcia V; Schwartzman ML
J Hypertens; 2022 Mar; 40(3):498-511. PubMed ID: 35081581
[TBL] [Abstract][Full Text] [Related]
9. 20-HETE and CYP4A2 ω-hydroxylase contribute to the elevated blood pressure in hyperandrogenemic female rats.
Dalmasso C; Maranon R; Patil C; Moulana M; Romero DG; Reckelhoff JF
Am J Physiol Renal Physiol; 2016 Jul; 311(1):F71-7. PubMed ID: 27194719
[TBL] [Abstract][Full Text] [Related]
10. CYP4A2-induced hypertension is 20-hydroxyeicosatetraenoic acid- and angiotensin II-dependent.
Sodhi K; Wu CC; Cheng J; Gotlinger K; Inoue K; Goli M; Falck JR; Abraham NG; Schwartzman ML
Hypertension; 2010 Nov; 56(5):871-8. PubMed ID: 20837888
[TBL] [Abstract][Full Text] [Related]
11. Contribution of iNOS/sGC/PKG pathway, COX-2, CYP4A1, and gp91(phox) to the protective effect of 5,14-HEDGE, a 20-HETE mimetic, against vasodilation, hypotension, tachycardia, and inflammation in a rat model of septic shock.
Tunctan B; Korkmaz B; Sari AN; Kacan M; Unsal D; Serin MS; Buharalioglu CK; Sahan-Firat S; Cuez T; Schunck WH; Manthati VL; Falck JR; Malik KU
Nitric Oxide; 2013 Sep; 33():18-41. PubMed ID: 23684565
[TBL] [Abstract][Full Text] [Related]
12. Transfection of CYP4A1 cDNA increases vascular reactivity in renal interlobar arteries.
Kaide J; Wang MH; Wang JS; Zhang F; Gopal VR; Falck JR; Nasjletti A; Laniado-Schwartzman M
Am J Physiol Renal Physiol; 2003 Jan; 284(1):F51-6. PubMed ID: 12388396
[TBL] [Abstract][Full Text] [Related]
13. Androgen-sensitive hypertension associated with soluble guanylate cyclase-α1 deficiency is mediated by 20-HETE.
Dordea AC; Vandenwijngaert S; Garcia V; Tainsh RE; Nathan DI; Allen K; Raher MJ; Tainsh LT; Zhang F; Lieb WS; Mikelman S; Kirby A; Stevens C; Thoonen R; Hindle AG; Sips PY; Falck JR; Daly MJ; Brouckaert P; Bloch KD; Bloch DB; Malhotra R; Schwartzman ML; Buys ES
Am J Physiol Heart Circ Physiol; 2016 Jun; 310(11):H1790-800. PubMed ID: 27199131
[TBL] [Abstract][Full Text] [Related]
14. Endothelial-specific CYP4A2 overexpression leads to renal injury and hypertension via increased production of 20-HETE.
Inoue K; Sodhi K; Puri N; Gotlinger KH; Cao J; Rezzani R; Falck JR; Abraham NG; Laniado-Schwartzman M
Am J Physiol Renal Physiol; 2009 Oct; 297(4):F875-84. PubMed ID: 19675180
[TBL] [Abstract][Full Text] [Related]
15. Elevated 20-HETE in metabolic syndrome regulates arterial stiffness and systolic hypertension via MMP12 activation.
Soler A; Hunter I; Joseph G; Hutcheson R; Hutcheson B; Yang J; Zhang FF; Joshi SR; Bradford C; Gotlinger KH; Maniyar R; Falck JR; Proctor S; Schwartzman ML; Gupte SA; Rocic P
J Mol Cell Cardiol; 2018 Apr; 117():88-99. PubMed ID: 29428638
[TBL] [Abstract][Full Text] [Related]
16. Inhibitors of 20-HETE formation promote salt-sensitive hypertension in rats.
Hoagland KM; Flasch AK; Roman RJ
Hypertension; 2003 Oct; 42(4):669-73. PubMed ID: 12874093
[TBL] [Abstract][Full Text] [Related]
17. Role of 20-Hydroxyeicosatetraenoic Acid (20-HETE) in Androgen-Mediated Cell Viability in Prostate Cancer Cells.
Colombero C; Papademetrio D; Sacca P; Mormandi E; Alvarez E; Nowicki S
Horm Cancer; 2017 Aug; 8(4):243-256. PubMed ID: 28639228
[TBL] [Abstract][Full Text] [Related]
18. The Blood Pressure-Lowering Effect of 20-HETE Blockade in
Pandey V; Garcia V; Gilani A; Mishra P; Zhang FF; Paudyal MP; Falck JR; Nasjletti A; Wang WH; Schwartzman ML
J Pharmacol Exp Ther; 2017 Dec; 363(3):412-418. PubMed ID: 28912346
[TBL] [Abstract][Full Text] [Related]
19. Hypertension is a major contributor to 20-hydroxyeicosatetraenoic acid-mediated kidney injury in diabetic nephropathy.
Gangadhariah MH; Luther JM; Garcia V; Paueksakon P; Zhang MZ; Hayward SW; Love HD; Falck JR; Manthati VL; Imig JD; Schwartzman ML; Zent R; Capdevila JH; Pozzi A
J Am Soc Nephrol; 2015 Mar; 26(3):597-610. PubMed ID: 25071086
[TBL] [Abstract][Full Text] [Related]
20. Role of 20-hydroxyeicosatetraenoic acid in altering vascular reactivity in diabetes.
Yousif MH; Benter IF; Dunn KM; Dahly-Vernon AJ; Akhtar S; Roman RJ
Auton Autacoid Pharmacol; 2009 Jan; 29(1-2):1-12. PubMed ID: 19302551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
